Cargando…

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?

Background and Objectives: Lactobacillus reuteri DSM 17938 (L. reuteri) is a probiotic that can colonize different human body sites, including primarily the gastrointestinal tract, but also the urinary tract, the skin, and breast milk. Literature data showed that the administration of L. reuteri can...

Descripción completa

Detalles Bibliográficos
Autores principales: Saviano, Angela, Brigida, Mattia, Migneco, Alessio, Gunawardena, Gayani, Zanza, Christian, Candelli, Marcello, Franceschi, Francesco, Ojetti, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306447/
https://www.ncbi.nlm.nih.gov/pubmed/34201542
http://dx.doi.org/10.3390/medicina57070643
_version_ 1783727813334925312
author Saviano, Angela
Brigida, Mattia
Migneco, Alessio
Gunawardena, Gayani
Zanza, Christian
Candelli, Marcello
Franceschi, Francesco
Ojetti, Veronica
author_facet Saviano, Angela
Brigida, Mattia
Migneco, Alessio
Gunawardena, Gayani
Zanza, Christian
Candelli, Marcello
Franceschi, Francesco
Ojetti, Veronica
author_sort Saviano, Angela
collection PubMed
description Background and Objectives: Lactobacillus reuteri DSM 17938 (L. reuteri) is a probiotic that can colonize different human body sites, including primarily the gastrointestinal tract, but also the urinary tract, the skin, and breast milk. Literature data showed that the administration of L. reuteri can be beneficial to human health. The aim of this review was to summarize current knowledge on the role of L. reuteri in the management of gastrointestinal symptoms, abdominal pain, diarrhea and constipation, both in adults and children, which are frequent reasons for admission to the emergency department (ED), in order to promote the best selection of probiotic type in the treatment of these uncomfortable and common symptoms. Materials and Methods: We searched articles on PubMed(®) from January 2011 to January 2021. Results: Numerous clinical studies suggested that L. reuteri may be helpful in modulating gut microbiota, eliminating infections, and attenuating the gastrointestinal symptoms of enteric colitis, antibiotic-associated diarrhea (also related to the treatment of Helicobacter pylori (HP) infection), irritable bowel syndrome, inflammatory bowel disease, and chronic constipation. In both children and in adults, L. reuteri shortens the duration of acute infectious diarrhea and improves abdominal pain in patients with colitis or inflammatory bowel disease. It can ameliorate dyspepsia and symptoms of gastritis in patients with HP infection. Moreover, it improves gut motility and chronic constipation. Conclusion: Currently, probiotics are widely used to prevent and treat numerous gastrointestinal disorders. In our opinion, L. reuteri meets all the requirements to be considered a safe, well-tolerated, and efficacious probiotic that is able to contribute to the beneficial effects on gut-human health, preventing and treating many gastrointestinal symptoms, and speeding up the recovery and discharge of patients accessing the emergency department.
format Online
Article
Text
id pubmed-8306447
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83064472021-07-25 Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin? Saviano, Angela Brigida, Mattia Migneco, Alessio Gunawardena, Gayani Zanza, Christian Candelli, Marcello Franceschi, Francesco Ojetti, Veronica Medicina (Kaunas) Review Background and Objectives: Lactobacillus reuteri DSM 17938 (L. reuteri) is a probiotic that can colonize different human body sites, including primarily the gastrointestinal tract, but also the urinary tract, the skin, and breast milk. Literature data showed that the administration of L. reuteri can be beneficial to human health. The aim of this review was to summarize current knowledge on the role of L. reuteri in the management of gastrointestinal symptoms, abdominal pain, diarrhea and constipation, both in adults and children, which are frequent reasons for admission to the emergency department (ED), in order to promote the best selection of probiotic type in the treatment of these uncomfortable and common symptoms. Materials and Methods: We searched articles on PubMed(®) from January 2011 to January 2021. Results: Numerous clinical studies suggested that L. reuteri may be helpful in modulating gut microbiota, eliminating infections, and attenuating the gastrointestinal symptoms of enteric colitis, antibiotic-associated diarrhea (also related to the treatment of Helicobacter pylori (HP) infection), irritable bowel syndrome, inflammatory bowel disease, and chronic constipation. In both children and in adults, L. reuteri shortens the duration of acute infectious diarrhea and improves abdominal pain in patients with colitis or inflammatory bowel disease. It can ameliorate dyspepsia and symptoms of gastritis in patients with HP infection. Moreover, it improves gut motility and chronic constipation. Conclusion: Currently, probiotics are widely used to prevent and treat numerous gastrointestinal disorders. In our opinion, L. reuteri meets all the requirements to be considered a safe, well-tolerated, and efficacious probiotic that is able to contribute to the beneficial effects on gut-human health, preventing and treating many gastrointestinal symptoms, and speeding up the recovery and discharge of patients accessing the emergency department. MDPI 2021-06-23 /pmc/articles/PMC8306447/ /pubmed/34201542 http://dx.doi.org/10.3390/medicina57070643 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Saviano, Angela
Brigida, Mattia
Migneco, Alessio
Gunawardena, Gayani
Zanza, Christian
Candelli, Marcello
Franceschi, Francesco
Ojetti, Veronica
Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
title Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
title_full Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
title_fullStr Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
title_full_unstemmed Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
title_short Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
title_sort lactobacillus reuteri dsm 17938 (limosilactobacillus reuteri) in diarrhea and constipation: two sides of the same coin?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306447/
https://www.ncbi.nlm.nih.gov/pubmed/34201542
http://dx.doi.org/10.3390/medicina57070643
work_keys_str_mv AT savianoangela lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin
AT brigidamattia lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin
AT mignecoalessio lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin
AT gunawardenagayani lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin
AT zanzachristian lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin
AT candellimarcello lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin
AT franceschifrancesco lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin
AT ojettiveronica lactobacillusreuteridsm17938limosilactobacillusreuteriindiarrheaandconstipationtwosidesofthesamecoin